Manuel Sobrinho-Simões

Author PubWeight™ 84.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002 4.43
2 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 2003 3.34
3 Frequency of TERT promoter mutations in human cancers. Nat Commun 2013 3.13
4 A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003 2.39
5 BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 2004 2.21
6 The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors. Mod Pathol 2011 2.08
7 TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab 2014 1.71
8 Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch 2005 1.62
9 Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol 2002 1.61
10 Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004 1.59
11 BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab 2004 1.52
12 How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer. J Thyroid Res 2011 1.46
13 Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case. Int J Surg Pathol 2013 1.46
14 Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid 2007 1.41
15 Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Arch 2001 1.30
16 STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci U S A 2012 1.23
17 Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands. Int J Surg Pathol 2014 1.10
18 Telomerase promoter mutations in cancer: an emerging molecular biomarker? Virchows Arch 2014 1.09
19 mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma. J Clin Endocrinol Metab 2012 1.08
20 A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol 2005 1.04
21 Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol 2004 1.01
22 High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. J Clin Endocrinol Metab 2007 1.01
23 p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol 2003 0.99
24 Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch 2001 0.98
25 BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch 2004 0.95
26 Prognostic biomarkers in thyroid cancer. Virchows Arch 2014 0.95
27 Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis. Int J Surg Pathol 2003 0.93
28 The biology and the genetics of Hurthle cell tumors of the thyroid. Endocr Relat Cancer 2012 0.92
29 Molecular genetics of papillary thyroid carcinoma: great expectations. Arq Bras Endocrinol Metabol 2007 0.92
30 Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. Am J Clin Pathol 2009 0.91
31 B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Hum Pathol 2006 0.91
32 A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations. Histopathology 2009 0.91
33 Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia. J Clin Endocrinol Metab 2003 0.90
34 BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion? Hum Pathol 2009 0.89
35 Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes. Genes Chromosomes Cancer 2012 0.88
36 A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto's thyroiditis susceptibility. J Clin Endocrinol Metab 2014 0.86
37 Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. BMC Cancer 2009 0.86
38 Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic? Int J Surg Pathol 2014 0.86
39 Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes. J Pathol 2005 0.85
40 Cancer: Small papillary thyroid cancers--is BRAF of prognostic value? Nat Rev Endocrinol 2011 0.85
41 RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas. Histopathology 2012 0.85
42 Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later. J Clin Endocrinol Metab 2013 0.84
43 A stem cell role for thyroid solid cell nests. Hum Pathol 2005 0.84
44 Small-cell (basaloid) thyroid carcinoma: a neoplasm with a solid cell nest histogenesis? Int J Surg Pathol 2011 0.83
45 Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique. Eur J Cancer Prev 2013 0.83
46 The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma. Hum Pathol 2006 0.83
47 Follicular, papillary, and "hybrid" carcinomas of the thyroid. Endocr Pathol 2002 0.83
48 GRIM-19 in Health and Disease. Adv Anat Pathol 2008 0.82
49 Absence of the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid. Am J Clin Pathol 2012 0.81
50 Mitochondria and cancer. Virchows Arch 2009 0.81
51 Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2008 0.81
52 The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases. Virchows Arch 2011 0.81
53 Head and neck lesions in a cohort irradiated in childhood for tinea capitis treatment. Lancet Infect Dis 2011 0.80
54 A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation. Int J Surg Pathol 2005 0.80
55 AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines. PLoS One 2012 0.80
56 CDX2 Expression in Some Variants of Papillary Thyroid Carcinoma. Am J Clin Pathol 2012 0.79
57 Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J Pathol 2002 0.79
58 Tumor-in-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component? Int J Surg Pathol 2011 0.79
59 Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy. Mitochondrion 2005 0.78
60 Small cell tumors of the thyroid gland: a review. Int J Surg Pathol 2013 0.78
61 Warthin's tumour. Virchows Arch 2006 0.78
62 Diagnostic criteria in well-differentiated thyroid carcinomas. Endocr Pathol 2006 0.78
63 Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features. Int J Surg Pathol 2013 0.78
64 Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett 2005 0.77
65 Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases. Histopathology 2013 0.77
66 In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp. Endocr Relat Cancer 2011 0.77
67 Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment. Eur J Endocrinol 2013 0.77
68 Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950-1963). Virchows Arch 2014 0.77
69 Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease). Virchows Arch 2014 0.76
70 A founder SDHB mutation in Portuguese paraganglioma patients. Endocr Relat Cancer 2013 0.76
71 Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth. Hum Pathol 2008 0.76
72 Alterations of the SDHD gene locus in midgut carcinoids. Genes Chromosomes Cancer 2003 0.76
73 Poorly Differentiated and Undifferentiated Thyroid Carcinomas. Turk Patoloji Derg 2015 0.76
74 Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch 2002 0.76
75 Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid. BMC Cancer 2004 0.75
76 Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582. Carcinogenesis 2003 0.75
77 Difficult cases of thyroid pathology. Endocr Pathol 2002 0.75
78 Is BRAF mutation screening useful for preoperative risk stratification in papillary thyroid cancer? Future Oncol 2009 0.75
79 Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'. Mod Pathol 2013 0.75
80 Hyalinizing trabecular tumor of the thyroid displaying neuroendocrine differentiation. Virchows Arch 2004 0.75
81 Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases. Am J Surg Pathol 2017 0.75
82 C-cell hyperplasia and papillary thyroid carcinoma. Int J Surg Pathol 2012 0.75
83 Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes. Cytogenet Genome Res 2017 0.75
84 Endoscopic ultrasonographic features of gastric mucosa-associated lymphoid tissue lymphoma with a 'pseudocircumvolutory' appearance. Can J Gastroenterol 2013 0.75
85 Cystic tumor of the atrioventricular node of the heart appears to be the heart equivalent of the solid cell nests (ultimobranchial rests) of the thyroid. Am J Clin Pathol 2005 0.75
86 Travelogue. Int J Surg Pathol 2010 0.75
87 The familial counterparts of follicular cell--derived thyroid tumors. Int J Surg Pathol 2010 0.75
88 MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism. Eur J Endocrinol 2012 0.75
89 Vascular invasion in thyroid and gastric carcinomas. Ultrastruct Pathol 2003 0.75